Identification of TMEM217 as a novel prognostic biomarker and potential therapeutic target in acute myeloid leukemia
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
KeAi Communications Co., Ltd.
2024-07-01
|
| Series: | Genes and Diseases |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352304223003070 |
| _version_ | 1827257193829761024 |
|---|---|
| author | Yunying Yao Zhizhou Xia Min Wu Bo Jiao Jiaming Gao Donghe Li Xi Xie Pengfei Xu Jiaoyang Li Lei Yan Ruibao Ren Ping Liu |
| author_facet | Yunying Yao Zhizhou Xia Min Wu Bo Jiao Jiaming Gao Donghe Li Xi Xie Pengfei Xu Jiaoyang Li Lei Yan Ruibao Ren Ping Liu |
| author_sort | Yunying Yao |
| collection | DOAJ |
| first_indexed | 2024-04-25T00:04:02Z |
| format | Article |
| id | doaj.art-b9ad62bb05d74fc99db758d5775fe2ad |
| institution | Directory Open Access Journal |
| issn | 2352-3042 |
| language | English |
| last_indexed | 2025-03-22T01:50:55Z |
| publishDate | 2024-07-01 |
| publisher | KeAi Communications Co., Ltd. |
| record_format | Article |
| series | Genes and Diseases |
| spelling | doaj.art-b9ad62bb05d74fc99db758d5775fe2ad2024-05-08T04:07:28ZengKeAi Communications Co., Ltd.Genes and Diseases2352-30422024-07-01114101037Identification of TMEM217 as a novel prognostic biomarker and potential therapeutic target in acute myeloid leukemiaYunying Yao0Zhizhou Xia1Min Wu2Bo Jiao3Jiaming Gao4Donghe Li5Xi Xie6Pengfei Xu7Jiaoyang Li8Lei Yan9Ruibao Ren10Ping Liu11Shanghai Institute of Hematology, State Key Laboratory for Medical Genomics, National Research Center for Translational Medicine, Collaborative Innovation Center of Hematology, Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai 200025, ChinaShanghai Institute of Hematology, State Key Laboratory for Medical Genomics, National Research Center for Translational Medicine, Collaborative Innovation Center of Hematology, Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai 200025, ChinaShanghai Institute of Hematology, State Key Laboratory for Medical Genomics, National Research Center for Translational Medicine, Collaborative Innovation Center of Hematology, Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai 200025, ChinaShanghai Institute of Hematology, State Key Laboratory for Medical Genomics, National Research Center for Translational Medicine, Collaborative Innovation Center of Hematology, Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai 200025, ChinaShanghai Institute of Hematology, State Key Laboratory for Medical Genomics, National Research Center for Translational Medicine, Collaborative Innovation Center of Hematology, Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai 200025, ChinaShanghai Institute of Hematology, State Key Laboratory for Medical Genomics, National Research Center for Translational Medicine, Collaborative Innovation Center of Hematology, Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai 200025, ChinaShanghai Institute of Hematology, State Key Laboratory for Medical Genomics, National Research Center for Translational Medicine, Collaborative Innovation Center of Hematology, Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai 200025, ChinaShanghai Institute of Hematology, State Key Laboratory for Medical Genomics, National Research Center for Translational Medicine, Collaborative Innovation Center of Hematology, Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai 200025, ChinaShanghai Institute of Hematology, State Key Laboratory for Medical Genomics, National Research Center for Translational Medicine, Collaborative Innovation Center of Hematology, Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai 200025, ChinaShanghai Institute of Hematology, State Key Laboratory for Medical Genomics, National Research Center for Translational Medicine, Collaborative Innovation Center of Hematology, Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai 200025, ChinaInternational Center for Aging and Cancer, Hainan Medical University, Haikou, Hainan 570102, China; Corresponding author. Tel.: +86 021 64370045 610601.Shanghai Institute of Hematology, State Key Laboratory for Medical Genomics, National Research Center for Translational Medicine, Collaborative Innovation Center of Hematology, Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China; Corresponding author. Tel.: +86 021 64370045 610806.http://www.sciencedirect.com/science/article/pii/S2352304223003070 |
| spellingShingle | Yunying Yao Zhizhou Xia Min Wu Bo Jiao Jiaming Gao Donghe Li Xi Xie Pengfei Xu Jiaoyang Li Lei Yan Ruibao Ren Ping Liu Identification of TMEM217 as a novel prognostic biomarker and potential therapeutic target in acute myeloid leukemia Genes and Diseases |
| title | Identification of TMEM217 as a novel prognostic biomarker and potential therapeutic target in acute myeloid leukemia |
| title_full | Identification of TMEM217 as a novel prognostic biomarker and potential therapeutic target in acute myeloid leukemia |
| title_fullStr | Identification of TMEM217 as a novel prognostic biomarker and potential therapeutic target in acute myeloid leukemia |
| title_full_unstemmed | Identification of TMEM217 as a novel prognostic biomarker and potential therapeutic target in acute myeloid leukemia |
| title_short | Identification of TMEM217 as a novel prognostic biomarker and potential therapeutic target in acute myeloid leukemia |
| title_sort | identification of tmem217 as a novel prognostic biomarker and potential therapeutic target in acute myeloid leukemia |
| url | http://www.sciencedirect.com/science/article/pii/S2352304223003070 |
| work_keys_str_mv | AT yunyingyao identificationoftmem217asanovelprognosticbiomarkerandpotentialtherapeutictargetinacutemyeloidleukemia AT zhizhouxia identificationoftmem217asanovelprognosticbiomarkerandpotentialtherapeutictargetinacutemyeloidleukemia AT minwu identificationoftmem217asanovelprognosticbiomarkerandpotentialtherapeutictargetinacutemyeloidleukemia AT bojiao identificationoftmem217asanovelprognosticbiomarkerandpotentialtherapeutictargetinacutemyeloidleukemia AT jiaminggao identificationoftmem217asanovelprognosticbiomarkerandpotentialtherapeutictargetinacutemyeloidleukemia AT dongheli identificationoftmem217asanovelprognosticbiomarkerandpotentialtherapeutictargetinacutemyeloidleukemia AT xixie identificationoftmem217asanovelprognosticbiomarkerandpotentialtherapeutictargetinacutemyeloidleukemia AT pengfeixu identificationoftmem217asanovelprognosticbiomarkerandpotentialtherapeutictargetinacutemyeloidleukemia AT jiaoyangli identificationoftmem217asanovelprognosticbiomarkerandpotentialtherapeutictargetinacutemyeloidleukemia AT leiyan identificationoftmem217asanovelprognosticbiomarkerandpotentialtherapeutictargetinacutemyeloidleukemia AT ruibaoren identificationoftmem217asanovelprognosticbiomarkerandpotentialtherapeutictargetinacutemyeloidleukemia AT pingliu identificationoftmem217asanovelprognosticbiomarkerandpotentialtherapeutictargetinacutemyeloidleukemia |